Pfizers COVID-19 vaccine gets full FDA approval

The Food and Drug Administration granted full approval to the Pfizer / BioNTech COVID-19 vaccine, another landmark in the historic immunization campaign. The vaccine was previously available to people over the age of 12 in the United States under an emergency use authorization. Now, it’s officially licensed in the United States.

With full approval, Pfizer and BioNTech can directly market the shot to consumers. The vaccine will be marketed under the name Comirnaty to people over 16. It will still be available to people 12-15 years old under an emergency use authorization.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic,” acting FDA Commissioner Janet Woodcock said in a statement. “While...

Continue reading…